News:
ePaper |
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Classifieds |
Jobs |
Obituary |
Andhra Pradesh
New Hepatitis A vaccine to hit the market soon
HYDERABAD: Chiron Panacea Vaccines Private Limited on Friday announced that a new generation Hepatitis A vaccine, HAVpur, will be launched in the Indian market in a week. Switzerland-based Berna Biotech has partnered with the company for marketing the vaccine, which is based on virosome technology.
At a press conference here, Christian Herzog, director (medical services), Berna Biotech and M.Indra Shekhar Rao, professor & head, Department of Pediatrics, Niloufer Hospital, said the vaccine is fully bio-degradable and has the advantage of not having an adjuvant that causes pain. Shafi Kolhapure, GM (medical affairs), said the vaccine would be priced around Rs.1,000 for each dose.
Dr. Rao said the Indian Academy of Pediatrics had endorsed Hepatitis A vaccination for children to be given in two doses. There was a shift in the epidemiology of the disease. Earlier, Hepatitis A was considered to be the disease of childhood and during the last five years, its prevalence was being observed in people aged between 15 and 20 years, he added.
Printer friendly
page
Send this article to Friends by
E-Mail
Andhra Pradesh
News:
ePaper |
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Classifieds |
Jobs |
Obituary |
Updates:
Breaking News |
|
